MENU

Healthcare

Federal Vaccine Mandates – Where Things Stand

Litigation, Government Relations, Health Care, Healthcare, Life Sciences, Public Policy /

Updated on December 7, 2021 All federal vaccine mandates stayed pending Court action   On September 9, 2021, President Biden issued Executive Order 14042: Ensuring Adequate COVID Safety Protocols for Federal Contractors which mandated that employees of federal contractors be fully vaccinated for COVID-19, following recommendations of the Safer Federal Workforce Task Force. In early November 2021, […]

Federal Vaccine Mandates – Where Things Stand Read More »

6th Circuit Selected in Lottery to Hear Lawsuits against OSHA ETS Vaccine and Testing Mandate

Agriculture & Agribusiness, CPSC, EPA, FDA, Government Relations, Health Care, Healthcare, Life Sciences, Public Policy, USDA, USDA FSIS /

On November 16, 2021, the Judicial Panel on Multidistrict Litigation, through a lottery system, drew the 6th Circuit as the U.S. Court of Appeals that will hear the consolidated lawsuits against the Occupational Health and Safety Administration (OSHA) Emergency Temporary Standard (ETS) published in the Federal Register on November 5, 2021. The OSHA ETS, which

6th Circuit Selected in Lottery to Hear Lawsuits against OSHA ETS Vaccine and Testing Mandate Read More »

Biden to Nominate Dr. Robert Califf as FDA Commissioner

FDA, Government Relations, Health Care, Healthcare /

On Friday November 12, 2021, President Biden nominated former United States Food and Drug Administration (FDA) Commissioner Dr. Robert Califf, a cardiologist by training, to again be FDA Commissioner, replacing acting Commissioner Dr. Janet Woodcock. Califf, 70, was the FDA Commissioner for a year at the end of the Obama Administration. He garnered broad support

Biden to Nominate Dr. Robert Califf as FDA Commissioner Read More »

UPDATE: Federal Contractor Vaccine Mandate

Agriculture & Agribusiness, FDA, Food Manufacturing, Processing, and Marketing, Government Relations, Health Care, Healthcare, USDA, USDA FSIS /

Federal Contractors are being given additional time and flexibility to address the vaccination mandate – Employees must be fully vaccinated by January 18, 2022.   The Department of Health and Human Services (HHS) and The United States Department of Agriculture (USDA) Contracting Officers Have Enormous Discretion To Add Vaccine Mandate Clause to Product Contracts.  

UPDATE: Federal Contractor Vaccine Mandate Read More »

OSHA Releases ETS on Vaccine and Testing Mandate

FDA, Government Relations, Health Care, Healthcare /

On November 4, 2021, the Occupational Safety and Health Administration’s (OSHA) released the prepublished version of its expected new emergency temporary standard (ETS). The OSHA ETS (interim final rule; request for comments) was published in the Federal Register on November 5, 2021. The OSHA ETS requires employers with 100 or more employees to mandate that all their

OSHA Releases ETS on Vaccine and Testing Mandate Read More »

FDA Notice of Proposed Rulemaking: Proposed Repeal of HHS Rules on Guidance, Enforcement, and Adjudication Procedures

FDA, Health Care, Healthcare, Life Sciences /

On October 20, the United States Department of Health and Human Services (HHS) published a Notice of Proposed Rulemaking that would, in relevant part, repeal a Trump Administration rule on, “Department of Health and Human Services Good Guidance Practices,” (GGP Rule) (Dec 7, 2020).    The GGP Rule required: Each guidance document issued by HHS

FDA Notice of Proposed Rulemaking: Proposed Repeal of HHS Rules on Guidance, Enforcement, and Adjudication Procedures Read More »

FDA Announces a DSCSA Public Meeting and Requests Comments

FDA, Health Care, Healthcare, Life Sciences /

The United States Food and Drug Administration (FDA) announced that it will be virtually hosting a public meeting on November 16, 2021, on Drug Supply Chain Security Act (DSCSA) implementation.  The purpose of this meeting is to allow interested stakeholders the opportunity to provide input to the FDA on the enhanced drug distribution security provisions

FDA Announces a DSCSA Public Meeting and Requests Comments Read More »

Long-Awaited DSCSA Guidances Published

FDA, Healthcare, Life Sciences /

On June 3, the Food and Drug Administration (FDA) released four  guidances implementing the Drug Supply Chain Security Act (DSCSA). Final Guidance for Industry: Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification  (Suspect Product Final Guidance) Final Guidance for Industry: Product Identifiers under the Drug Supply Chain Security Act – Questions

Long-Awaited DSCSA Guidances Published Read More »

FDA Reverses Trump Administration’s Unapproved Drugs Policy

FDA, Healthcare, Life Sciences /

On May 26, the Food and Drug Administration (FDA) reversed a Trump Administration policy that revoked the agency’s longstanding Unapproved Drugs Initiative (UDI).  On November 15, 2020, then HHS Secretary Alex Azar issued a notice and a request for information entitled “Termination of the Food and Drug Administration’s Unapproved Drugs Initiative; Request for Information Regarding

FDA Reverses Trump Administration’s Unapproved Drugs Policy Read More »

FDA Reverses a Trump Administration Drug Review Transparency Policy

FDA, Healthcare, Life Sciences /

On April 30, the Food and Drug Administration (FDA) reversed a  Policy issued by the Department of Health and Human Services (HHS) near the end of the Trump Administration that was purportedly intended to increase drug review timeline transparency.  The Policy was announced in the Federal Register on January 15 and would have required FDA

FDA Reverses a Trump Administration Drug Review Transparency Policy Read More »

Federal Trade Commission Announces New Multilateral Working Group to Examine Pharma Mergers

Healthcare /

On March 16, Rebecca Kelly Slaughter, the Acting Chair of the Federal Trade Commission (FTC) announced that the agency will create a working group to revise its approach used to analyze the effects of pharmaceutical mergers. The group will include the Department of Justice’s Antitrust Division, state attorneys general, and foreign antitrust agencies including the

Federal Trade Commission Announces New Multilateral Working Group to Examine Pharma Mergers Read More »

Health Groups Sue HHS in Response to Trump Administration’s “Sunset Rule”

Healthcare, Government Relations, Public Policy /

On March 9, several health groups including the American Lung Association and the Center for Science in the Public Interest joined Santa Clara County, California and other advocacy groups in a lawsuit against the Department of Health and Human Services (HHS) over the Trump administration’s “sunset rule” in the U.S. District Court for the Northern

Health Groups Sue HHS in Response to Trump Administration’s “Sunset Rule” Read More »

CDRH Cracks Down on Misleading “Registration Certificates”

FDA, Healthcare /

On March 3, Rear Admiral Sean Boyd, Director of the Office of Regulatory Programs at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) announced an uptick in firms selling and issuing fraudulent “FDA registration certificates” which indicate that a medical device has been authorized, approved, cleared, or reviewed by the

CDRH Cracks Down on Misleading “Registration Certificates” Read More »

Janet Woodcock is Named Acting FDA Commissioner, As Stephen Hahn Steps Down

Healthcare, Life Sciences /

In typical fashion, as the new administration took over, i.e., as President Biden was sworn in on Wednesday, Dr. Stephen M. Hahn resigned as FDA Commissioner.  His resignation was part of the routine departure of political appointees seen when a new President takes office. Dr. Janet Woodcock has become Acting Commissioner on an interim basis,

Janet Woodcock is Named Acting FDA Commissioner, As Stephen Hahn Steps Down Read More »

HHS’s Last Ditch Policy Moves – What is the End Game?

Healthcare, Government Relations /

Earlier this month, the Department of Health and Human Services (HHS) published a proposed rule that would require sunset dates for its regulations, including regulations under its agencies like the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS). The proposed rule, “Securing Updated and Necessary Statutory Evaluations Timely,” flew

HHS’s Last Ditch Policy Moves – What is the End Game? Read More »

FDA announces enforcement discretion and 3-year delay in DSCSA Requirements for Wholesale Distributors and Dispensers

Healthcare /

This week, the Food and Drug Administration (FDA) announced release of a new guidance for immediate implementation that extends for another 3 years, until November 27, 2023, its enforcement discretion regarding verification of a prescription drug returns prior to resale.  FDA also announced that it is delaying until November 27, 2023, its requirement that pharmacies

FDA announces enforcement discretion and 3-year delay in DSCSA Requirements for Wholesale Distributors and Dispensers Read More »

QHC for Cranberry Products and Reduced Risk of Recurrent Urinary Tract Infection in Healthy Women

Healthcare, Agriculture & Agribusiness /

FDA has published a letter of enforcement discretion, which it sent to legal counsel for Ocean Spray Cranberries, Inc., that authorizes a qualified health claim (QHC) for specific cranberry products when consumed in specific amounts by specific people. The substantiation for the diet-disease relationship warranted a “limited and inconsistent” or “limited” scientific evidence qualifier. Based on

QHC for Cranberry Products and Reduced Risk of Recurrent Urinary Tract Infection in Healthy Women Read More »

OFW logo white

We provide legal, regulatory, and advocacy services for clients regulated by FDA, USDA, and CBP.

FIRM
INDUSTRIES
Food & Agriculture
Customs and Trade
Consumer and Commercial Litigation
Cannabis

NEWSLETTER

Subscribe to our newsletter and stay up to date:
Facebook-f Linkedin-in Twitter
Copyright 2020. All rights reserved. Sitemap.
Built and powered by Direction.com​

Industries

Food & Agriculture
Medical Products
Customs and Trade
Consumer and Commercial Litigation
Cannabis

Our Firm

Home
People
About
Contact

Insights

News & Insights
Facebook Twitter Linkedin